Edwin Alyea
Instructor in the Department of Medicine
Positions
Instructor in the Department of Medicine in the School of Medicine
2020 School of Medicine
Member of the Duke Cancer Institute in the School of Medicine
2022 School of Medicine
Education
M.D. 1989
1989 Duke University School of Medicine
Residency, Internal Medicine
1992 Brigham and Women's Hospital
Fellowship, Medical Oncology
1995 Dana-Farber Cancer Institute
Publications, Grants & Awards
- Academics Articles (13)
- Conference Pages (1)
Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease.
Journal of Clinical Oncology
Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantatio
Journal of Clinical Oncology
Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia.
Biol Blood Marrow Transplant
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.
Journal of Clinical Oncology
Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.
Journal of Clinical Oncology
Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncol
Journal of Clinical Oncology
Post-transplantation B cell activating factor and B cell recovery before onset of chronic graft-versus-host disease.
Biol Blood Marrow Transplant
Combined CD4 T-cell and antibody response to human minor histocompatibility antigen DBY after allogeneic stem-cell transplantation.
Transplantation